MedPath

Effect of sage on health of women with polycystic ovary syndrome

Not Applicable
Conditions
Policyctic ovary syndrome.
Sclerocystic ovary syndrome Stein-Leventhal syndrome
Registration Number
IRCT201504146917N2
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

1-The samples should have the desire to participate in the study and informed consent was taken from them. 2- They should have Iranian nationality. 3- Don’t use food and drug supplements such as vitamins, minerals... 4- They shouldn't be on a special diet such as Low-sugar, low-fat or vegetarian diets. 5- Absence of known mental illness or chronic physical disease according to the information given from the patient. 6- They shouldn't be pregnant and has no desire to become pregnant during the study. 7- The participant and her wife, shouldn't be addicted to drugs and also shouldn't take any tranquilizers or psychotropic substances.
8 -Hormonal drugs (except oral contraceptive compounds), reducing or increasing the weight compounds, the blood lipid lowering drugs, the blood glucose lowering drugs and Anti-epileptic drugs should not have been used during the study and two months before it. 9- They are not undergoing infertility treatment. 10- They should not have been under the influence of stressful events during the last three months.
Exclusion criteria: 1- Participants withdrew from participating in the study at any part of study.
2- In case of intolerable or harmful side effects, such as severe nausea and vomiting or allergy caused by the salvia officinalis capsules.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath